Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nodal occult metastases in intermediate- and high-risk prostate cancer patients detected using serial section, immunohistochemistry, and real-time reverse transcriptase polymerase chain reaction: prospective evaluation with matched-pair analysis.
Schiavina R, Capizzi E, Borghesi M, Vagnoni V, Romagnoli D, Rocca GC, Giunchi F, D'Errico A, De Giovanni A, Rizzi S, Brunocilla E, Martorana G, Fiorentino M. Schiavina R, et al. Among authors: rizzi s. Clin Genitourin Cancer. 2015 Apr;13(2):e55-64. doi: 10.1016/j.clgc.2014.08.004. Epub 2014 Aug 9. Clin Genitourin Cancer. 2015. PMID: 25212578
Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
Schiavina R, Borghesi M, Brunocilla E, Manferrari F, Fiorentino M, Vagnoni V, Baccos A, Pultrone CV, Rocca GC, Rizzi S, Martorana G. Schiavina R, et al. Among authors: rizzi s. BJU Int. 2013 Jun;111(8):1237-44. doi: 10.1111/j.1464-410X.2012.11602.x. Epub 2013 Jan 17. BJU Int. 2013. PMID: 23331345
Revised Gleason grading system is a better predictor of indolent prostate cancer at the time of diagnosis: retrospective clinical-pathological study on matched biopsy and radical prostatectomy specimens.
Giunchi F, Brunocilla E, Borghesi M, Rizzi S, Ricci MS, Romagnoli D, Martorana G, Schiavina R, Fiorentino M. Giunchi F, et al. Among authors: rizzi s. Clin Genitourin Cancer. 2014 Oct;12(5):325-9. doi: 10.1016/j.clgc.2014.01.009. Epub 2014 Feb 4. Clin Genitourin Cancer. 2014. PMID: 24583160
The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma.
Schiavina R, Borghesi M, Chessa F, Dababneh H, Bianchi L, Della Mora L, Del Prete C, Longhi B, Rizzi S, Fiorentino M, Martorana G, Brunocilla E. Schiavina R, et al. Among authors: rizzi s. Clin Genitourin Cancer. 2015 Aug;13(4):e235-e241. doi: 10.1016/j.clgc.2014.06.011. Epub 2014 Jun 11. Clin Genitourin Cancer. 2015. PMID: 26174224
Adverse Features and Competing Risk Mortality in Patients With High-Risk Prostate Cancer.
Vagnoni V, Bianchi L, Borghesi M, Pultrone CV, Dababneh H, Chessa F, La Manna G, Rizzi S, Porreca A, Brunocilla E, Martorana G, Schiavina R. Vagnoni V, et al. Among authors: rizzi s. Clin Genitourin Cancer. 2017 Apr;15(2):e239-e248. doi: 10.1016/j.clgc.2016.08.016. Epub 2016 Aug 25. Clin Genitourin Cancer. 2017. PMID: 27641658
Survival, Continence and Potency (SCP) recovery after radical retropubic prostatectomy: a long-term combined evaluation of surgical outcomes.
Schiavina R, Borghesi M, Dababneh H, Pultrone CV, Chessa F, Concetti S, Gentile G, Vagnoni V, Romagnoli D, Della Mora L, Rizzi S, Martorana G, Brunocilla E. Schiavina R, et al. Among authors: rizzi s. Eur J Surg Oncol. 2014 Dec;40(12):1716-23. doi: 10.1016/j.ejso.2014.06.015. Epub 2014 Jul 18. Eur J Surg Oncol. 2014. PMID: 25085795
291 results